Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry

NCT05081336

Acute Coronary Syndrome Dyslipidemias

UNKNOWN

InPractice Survey on the Treatment of Hypercholesterolemia

NCT00523796

Hypercholesterolemia

COMPLETED

Familial Atherosclerosis Treatment Study

NCT00000512

Cardiovascular Diseases Coronary Arteriosclerosis Coronary Disease +2 more

COMPLETED PHASE3

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

NCT01190072

Coronary Artery Disease

TERMINATED

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

NCT01372956

Dyslipidemia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients with hypercholesterolemia on lipid lowering pharmacological treatment

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients on lipid lowering drug treatment
* Lipid lowering drug treatment lasting at least 3 months
* No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study

Exclusion Criteria

* Lack of patient's signed informed consent form
* Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No